Progress towards a public chemogenomic set for protein kinases and a call for contributions.
Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic s...
Saved in:
| Main Authors: | David H Drewry, Carrow I Wells, David M Andrews, Richard Angell, Hassan Al-Ali, Alison D Axtman, Stephen J Capuzzi, Jonathan M Elkins, Peter Ettmayer, Mathias Frederiksen, Opher Gileadi, Nathanael Gray, Alice Hooper, Stefan Knapp, Stefan Laufer, Ulrich Luecking, Michael Michaelides, Susanne Müller, Eugene Muratov, R Aldrin Denny, Kumar S Saikatendu, Daniel K Treiber, William J Zuercher, Timothy M Willson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181585&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemogenomics for steroid hormone receptors (NR3)
by: Espen Schallmayer, et al.
Published: (2025-02-01) -
Chemogenomic profiling predicts antifungal synergies
by: Gregor Jansen, et al.
Published: (2009-12-01) -
Dissecting a complex chemical stress: chemogenomic profiling of plant hydrolysates
by: Jeffrey M Skerker, et al.
Published: (2013-06-01) -
Cross‐species chemogenomic profiling reveals evolutionarily conserved drug mode of action
by: Laura Kapitzky, et al.
Published: (2010-12-01) -
Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation.
by: Grace Mugumbate, et al.
Published: (2015-01-01)